NCT06610344View on ClinicalTrials.gov

BHB & CAR-T for Lymphomas

NARecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

October 15, 2025

Study Completion Date

October 15, 2026

Conditions
Large B-cell Lymphoma
Interventions
DIETARY_SUPPLEMENT

R-1,3-Butanediol

R-1,3-Butanediol 35 mL

Trial Locations (1)

19104

RECRUITING

Abramson Cancer Center at University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER